CareFusion emerged in 2009 as a bold spin-off from Cardinal Health, driven by a mission to combat two of healthcare's most dangerous threats: medication errors and hospital-acquired infections. Born from a collection of iconic medical tech brands like Pyxis, Alaris, IVAC, and IMED, CareFusion quickly became a titan in patient safety innovation. Its flagship product, the Pyxis Automated Dispensing Cabinet, revolutionized medication management by acting as a secure, intelligent 'vending machine for drugs,' reducing dispensing errors and streamlining workflows for nurses and pharmacists. Paired with Alaris smart infusion pumps, which introduced built-in safety protocols and error detection during intravenous drug administration, CareFusion created an end-to-end system that significantly enhanced medication safety across hospitals. Beyond its groundbreaking technology, the company also played a role in infection prevention through products like ChloraPrep, an antiseptic solution used before surgery. However, CareFusion’s journey wasn’t without controversy—its 2014 $40.1 million settlement with the U.S. Department of Justice over allegations of off-label marketing and kickbacks cast a shadow on its reputation. Despite this, CareFusion remained a powerful force in medical tech until its acquisition by BD (Becton, Dickinson and Company) in 2015 for $12.2 billion. Under BD, the legacy of CareFusion continues through integrated systems like the BD Pyxis MedStation ES and BD Alaris Infusion Pumps, now standard tools in modern hospitals worldwide. These innovations continue to evolve, incorporating real-time data tracking, AI-driven alerts, and deeper integration with electronic health records. As automation and connectivity reshape the future of medicine, CareFusion’s foundational work remains central to safer, more efficient patient care.